Arcutis Biotherapeutics (ARQT) Operating Income: 2021-2025
Historic Operating Income for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Sep 2025 value amounting to $8.5 million.
- Arcutis Biotherapeutics' Operating Income rose 121.82% to $8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$38.2 million, marking a year-over-year increase of 78.98%. This contributed to the annual value of -$128.4 million for FY2024, which is 46.75% up from last year.
- According to the latest figures from Q3 2025, Arcutis Biotherapeutics' Operating Income is $8.5 million, which was up 158.35% from -$14.6 million recorded in Q2 2025.
- In the past 5 years, Arcutis Biotherapeutics' Operating Income registered a high of $8.5 million during Q3 2025, and its lowest value of -$104.7 million during Q3 2022.
- Moreover, its 3-year median value for Operating Income was -$36.9 million (2023), whereas its average is -$36.4 million.
- Per our database at Business Quant, Arcutis Biotherapeutics' Operating Income slumped by 83.52% in 2022 and then skyrocketed by 121.82% in 2025.
- Quarterly analysis of 5 years shows Arcutis Biotherapeutics' Operating Income stood at -$71.3 million in 2021, then increased by 4.01% to -$68.4 million in 2022, then grew by 10.60% to -$61.2 million in 2023, then skyrocketed by 87.52% to -$7.6 million in 2024, then soared by 121.82% to $8.5 million in 2025.
- Its last three reported values are $8.5 million in Q3 2025, -$14.6 million for Q2 2025, and -$24.5 million during Q1 2025.